10x Genomics Opens Well Above IPO Price

10x Genomics TXG made its public debut Thursday morning, opening at $54 after being priced at $39 per share.

The firm plans to trade on the Nasdaq under ticker symbol "TXG.”

See Aslo: 10X Genomics IPO: What You Need To Know

10x Genomics markets the Chromium single-cell analysis system and assay kits, announced its plans for an IPO last month. Initially, its filing said it was looking to raise up to $100 million.

JPMorgan, Goldman Sachs and Bank of America Merrill Lynch are acting as lead joint book-running managers for the offering. Cowen is acting as lead manager for the offering.